SCHEMBL8084562

SCHEMBL8084562

COc1ccc(-n2nc(C(=O)ON)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1

nearest known ligand 0.82

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
F10 P00742 20/20 0.82
F2 P00734 5/20 0.82
SLC29A1 Q99808 1/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15883174 0.92 F10 (0.82) F10F2SLC29A1
SCHEMBL23777828 0.92 F10 (0.82) F10F2SLC29A1
Apixaban SCHEMBL118023 0.90 F10 (1.00) F10F2SLC29A1
SCHEMBL18365276 0.90 F10 (0.85) F10F2SLC29A1
Apixaban SCHEMBL15534161 0.90 F10 (0.98) F10F2SLC29A1
Apixaban SCHEMBL14672486 0.90 F10 (0.98) F10F2SLC29A1
Apixaban SCHEMBL5445904 0.90 F10 (0.98) F10F2SLC29A1
SCHEMBL19086463 0.90 F10 (0.98) F10F2SLC29A1
SCHEMBL5445803 0.89 F10 (0.84) F10F2SLC29A1
SCHEMBL541837 0.89 F10 (0.77) F10F2SLC29A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009018807-A9 OXAZOLIDINONES AS FACTOR XA INHIBITORS, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF IN THERAPY SCHEBO BIOTECH AG (DE) 2009-11-12 WO disclosed
WO-2009018807-A1 NOVEL PHARMACEUTICALS, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF IN THERAPY SCHEBO BIOTECH AG (DE) 2009-02-12 WO disclosed